|
December 21, 2021
|
Histogen Announces Closing of $3.5 Million Private Placement
|
|
|
December 16, 2021
|
Histogen Announces $3.5 Million Private Placement
|
|
|
November 10, 2021
|
Histogen Reports Third Quarter 2021 Earnings and Provides Business Update
|
|
|
November 8, 2021
|
Histogen Announces CEO Transition
|
|
|
November 2, 2021
|
Histogen and Amerimmune Announce the Presentation of Emricasan Data in COVID-19 at the American College of Allergy, Asthma, and Immunology Conference
|
|
|
October 27, 2021
|
Histogen to Report Third Quarter 2021 Financial Results on November 10, 2021
|
|
|
August 31, 2021
|
Histogen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
|
|
|
August 16, 2021
|
Histogen and Amerimmune Announce Additional Findings from its Phase 1 Study of Emricasan in Mild Symptomatic COVID-19 Patients
|
|
|
August 11, 2021
|
Histogen Reports Second Quarter 2021 Earnings and Provides Business Update
|
|
|
July 29, 2021
|
Histogen to Present at the Canaccord Genuity 41st Annual Growth Conference
|
|
